Bertucci Alexandre Albuquerque, Volpe-Chaves Cláudia Elizabeth, Mendo Diogo Melo, Andrade Úrsulla Vilella, Lacerda Mara Luci Goncalves Galiz, Venturini James, Saad Bruna Abdul Ahad, Oliveira Caroline Tieppo Flores de, Oliveira Sandra Maria do Valle Leone de, Paniago Anamaria Mello Miranda
Maria Aparecida Pedrossian University Hospital, Campo Grande, Mato Grosso do Sul, Brazil; Graduate Program in Infectious and Parasitic Diseases at the Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Maria Aparecida Pedrossian University Hospital, Campo Grande, Mato Grosso do Sul, Brazil; Hospital Regional de Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Multidiscip Respir Med. 2024 Dec 5;19(1):989. doi: 10.5826/mrm.2024.989.
Chronic pulmonary aspergillosis (CPA) often develops in residual lesions of pulmonary tuberculosis (PTB). Every year, 112,000 to 160,000 people worldwide will develop post-PTB CPA. The simultaneous occurrence of CPA with the first episode of PTB is rare. During the COVID-19 pandemic, COVID-19- associated invasive aspergillosis (CAPA) occurred in patients receiving high doses of corticosteroids and mechanical ventilation. However, CPA and COVID-19 are rarely reported simultaneously. This case study presents a patient with CPA in the first episode of PTB during hospitalization for COVID-19. The favorable evolution is highlighted, including the resolution of the cavitation and fungal ball with appropriate and early treatment.
A 48-year-old female patient from the Central West of Brazil was admitted with a history of cough, yellow sputum, fever, and significant weight loss for two months. The respiratory symptoms worsened one week before admission. She tested positive for COVID-19 by RT-PCR. She had a history of hypertension and diabetes. Clinical examination revealed tachypnea, slurred speech, and hypoxia. She presented with hyperglycemia, obesity, hypertension, and an episode of hemoptysis. Chest CT revealed cavitation in the right upper lobe with a 45 mm aspergilloma, multifocal morning opacities, and nodular opacities. Laboratory tests confirmed the PTB with positive sputum for acid-fast bacilli and positive culture for Mycobacterium tuberculosis. The sputum culture also showed Aspergillus spp. She received early treatment for bacterial pneumonia with ceftriaxone, dexamethasone, enoxaparin, an anti-TB regimen, and itraconazole. There was a progressive clinical improvement and the patient was discharged after 15 days. She completed six months of anti-TB therapy and 13 months of itraconazole treatment for CPA, with complete resolution of the cavitation and aspergilloma.
This case study presents a unique case of CPA that manifested as simple aspergilloma and was diagnosed concurrently with the initial episode of PTB in a COVID-19 patient with obesity, hypertension, and diabetes. Remarkably, the fungal ball and cavitation regressed spontaneously. The favorable clinical and radiological results highlight the importance of comprehensive treatment approaches for concurrent respiratory infections and emphasize the need to investigate CPA and PTB during COVID-19 hospitalization.
慢性肺曲霉病(CPA)常发生于肺结核(PTB)的残留病灶中。全球每年有11.2万至16万人会发生肺结核后慢性肺曲霉病。CPA与PTB首发同时出现的情况罕见。在新冠疫情期间,接受高剂量皮质类固醇和机械通气的患者发生了与新冠相关的侵袭性曲霉病(CAPA)。然而,CPA和新冠同时报告的情况很少见。本病例研究介绍了一名在因新冠住院期间PTB首发时合并CPA的患者。强调了良好的病情发展,包括通过适当和早期治疗使空洞和真菌球消失。
一名来自巴西中西部的48岁女性患者因咳嗽、黄痰、发热和体重显著减轻两个月的病史入院。入院前一周呼吸道症状加重。她经逆转录聚合酶链反应(RT-PCR)检测新冠呈阳性。她有高血压和糖尿病病史。临床检查发现呼吸急促、言语含糊和缺氧。她还存在高血糖、肥胖、高血压以及一次咯血发作。胸部CT显示右上叶有空洞,伴有一个45毫米的曲菌球、多灶性磨玻璃影和结节状阴影。实验室检查通过痰涂片抗酸杆菌阳性和结核分枝杆菌培养阳性确诊为肺结核。痰培养还显示有曲霉属。她接受了头孢曲松、地塞米松、依诺肝素、抗结核方案和伊曲康唑治疗细菌性肺炎。临床症状逐渐改善,患者15天后出院。她完成了六个月的抗结核治疗和13个月的伊曲康唑治疗CPA,空洞和曲菌球完全消失。
本病例研究介绍了一例独特的CPA病例,表现为单纯曲菌球,在一名患有肥胖、高血压和糖尿病的新冠患者中与PTB首发同时被诊断。值得注意的是,真菌球和空洞自行消退。良好的临床和影像学结果突出了针对并发呼吸道感染的综合治疗方法的重要性,并强调了在新冠住院期间对CPA和PTB进行调查的必要性。